Pharmafile Logo

Maximize Conference Impact Virtually – Engaging Your Advisors Creatively

July 10, 2025 |  

Extend the impact of scientific conferences! Discover how to creatively empower your advisors to share patient cases and evidence, sparking rich discussions on clinical implications and research questions. Drive deeper engagement post-congress!

Transform your post-conference engagement and extend the life of valuable insights. Explore innovative ways to leverage virtual platforms for congress coverage and post-conference engagement initiatives. Empower your advisors to share patient cases, digest emerging evidence from sessions, and spark deep discussions on data significance, clinical implications, and unanswered research questions. Learn how to foster ownership and generate rich, ongoing dialogue long after the live event concludes.

  1. Congress Coverage and Post-Conference Engagement Initiatives
    • Enable advisors to submit patient cases or evidence digests from live conferences.
    • Facilitate thought-provoking discussions on data, clinical implications, and research questions.
    • Empower advisors to moderate their own questions, fostering ownership and deeper engagement.
    • Extend the impact of conference sessions through sustained virtual dialogue.

For more creative ways to engage your advisors, visit: https://www.impetusdigital.com/2019/11/15/top-10-creative-ways-to-engage-your-advisors/

Learn more about Impetus Digital’s solutions: www.impetusdigital.com

Schedule a consultation: https://meetwithimpetus.com/

Stay connected:

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions

In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today’s diverse healthcare landscape. 7….

Trends in Virtual Collaboration

Join us for a look at the top-5 emerging virtual collaboration trends…

Advisor Questions on Potential Data or Knowledge Gaps

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here’s another one to keep in…

On a journey to diverse, inclusive, and more efficient rare disease trials

Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care…

Versatility! Top 10 benefits of virtual advisory boards

Here’s another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #10. Versatility! Another major advantage of using a virtual platform…

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story

In the early lead-up to our client’s multi-center Rare Disease Phase 3 Clinical Trial, they first conducted an internal engagement planning Longitudinal Expert Engagement Plan™ (LEEP™) to conduct an informal…

New Playbook Alert: Virtual Patient Engagement

Authentic patient engagement and insight-gathering are becoming must-haves in Pharma. However, multiple obstacles remain before patient-centricity becomes more than a buzzword. In our latest playbook, we take a deep dive…

No “White Space” Between Live Meetings; the top 10 benefits of virtual advisory boards

Here’s another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #9. No More “White Space” Between Live Meetings Clearly, the…

The problem with clinical trials (and how virtual insight-gathering can help)

While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access.

Ease and Effectiveness of Knowledge Sharing; the top 10 benefits of virtual advisory boards

Here’s another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #8. The Ease and Effectiveness of Sharing Knowledge and Data…